Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: 000250)

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 54.89B KRW in the quarter ending June 30, 2024, with 15.36% growth. This brings the company's revenue in the last twelve months to 204.28B, up 13.45% year-over-year. In the year 2023, Sam Chun Dang Pharm. had annual revenue of 192.67B with 8.65% growth.

• Revenue (ttm): 204.28B
• Revenue Growth: +13.45%
• P/S Ratio: 15.80
• Revenue / Employee: 510.70M
• Employees: 400
• Market Cap: 3,295.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	192.67B	15.33B	8.65%
Dec 31, 2022	177.34B	10.06B	6.01%
Dec 31, 2021	167.27B	412.57M	0.25%
Dec 31, 2020	166.86B	-19.74B	-10.58%
Dec 31, 2019	186.60B	26.64B	16.66%